FDA Adverse Event Injury Summary report: N

VOLLURE (VOLUME UNKNOWN)

MDR report key: 8316687 · Received February 7, 2019

Report

Report Number
3005113652-2019-00123
Event Type
Injury
Date Received
February 7, 2019
Date of Event
August 22, 2018
Report Date
February 7, 2019
Manufacturer
ALLERGAN (PRINGY)
Product Code
LMH
PMA / PMN Number
P110033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENT OF "NODULE FORMATION" IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED A PATIENT WAS INJECTED IN THE CHEEKS, NASOLABIAL FOLDS, LIPS, AND THE MELOLABIAL FOLDS WITH 2CC OF JUVÉDERM VOLUMA® XC, 3CC OF JUVÉDERM VOLLURE¿ XC, AND 1 CC OF JUVÉDERM VOLBELLA® XC. IT WAS NOT SPECIFIED WHICH FILLER WAS INJECTED INTO WHAT AREA. SEVEN MONTHS LATER, THE PATIENT DEVELOPED A ¿NODULE FORMATION.¿ THE PATIENT WAS TREATED TWO WEEKS LATER WITH PREDNISONE AND HYLENEX AND AGAIN TWO WEEKS LATER, 16 DAYS LATER, AND 6 DAYS LATER. THE PHYSICIAN STATED THAT THEY GAVE THE PATIENT ¿PREDNISONE FOR 16 DAYS AND HYLENEX FOR FIRST SEVERAL APPOINTMENTS THEN HYLENEX AND 1 LC.¿ THE SYMPTOMS FULLY RESOLVED APPROXIMATELY 10 MONTHS POST INJECTION. THIS IS THE SAME EVENT AND THE SAME PATIENT REPORTED UNDER MDR ID # 3005113652-2019-00121 (ALLERGAN COMPLAINT # (B)(4)) AND MDR ID # 3005113652-2019-00124 (ALLERGAN COMPLAINT # (B)(4)) JUVÉDERM VOLBELLA® XC. THIS IS THE FIRST MDR SUBMITTED FOR THE SECOND SUSPECT PRODUCT, JUVÉDERM VOLLURE¿ XC.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
108502 VOLLURE (VOLUME UNKNOWN) IMPLANT, DERMAL, FOR AESTHETIC USE LMH ALLERGAN (PRINGY) NI

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention JUVÉDERM VOLBELLA® XC, JUVÉDERM VOLUMA® XC